BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 22641041)

  • 21. Invariability of central metabolic flux distribution in Shewanella oneidensis MR-1 under environmental or genetic perturbations.
    Tang YJ; Martin HG; Deutschbauer A; Feng X; Huang R; Llora X; Arkin A; Keasling JD
    Biotechnol Prog; 2009; 25(5):1254-9. PubMed ID: 19610125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic flux analysis at ultra short time scale: isotopically non-stationary 13C labeling experiments.
    Nöh K; Grönke K; Luo B; Takors R; Oldiges M; Wiechert W
    J Biotechnol; 2007 Apr; 129(2):249-67. PubMed ID: 17207877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-scale model for Clostridium acetobutylicum: Part II. Development of specific proton flux states and numerically determined sub-systems.
    Senger RS; Papoutsakis ET
    Biotechnol Bioeng; 2008 Dec; 101(5):1053-71. PubMed ID: 18767191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of metabolic limitations during recombinant protein production in Escherichia coli.
    Heyland J; Blank LM; Schmid A
    J Biotechnol; 2011 Sep; 155(2):178-84. PubMed ID: 21723332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monte Carlo sampling and principal component analysis of flux distributions yield topological and modular information on metabolic networks.
    Sariyar B; Perk S; Akman U; Hortaçsu A
    J Theor Biol; 2006 Sep; 242(2):389-400. PubMed ID: 16860341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining pathway analysis with flux balance analysis for the comprehensive study of metabolic systems.
    Schilling CH; Edwards JS; Letscher D; Palsson BØ
    Biotechnol Bioeng; 2000-2001; 71(4):286-306. PubMed ID: 11291038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic flux analysis and visualization.
    Toya Y; Kono N; Arakawa K; Tomita M
    J Proteome Res; 2011 Aug; 10(8):3313-23. PubMed ID: 21815690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 13C metabolic flux analysis at a genome-scale.
    Gopalakrishnan S; Maranas CD
    Metab Eng; 2015 Nov; 32():12-22. PubMed ID: 26358840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic metabolic modelling of overproduced protein secretion in Streptomyces lividans using adaptive DFBA.
    Valverde JR; Gullón S; García-Herrero CA; Campoy I; Mellado RP
    BMC Microbiol; 2019 Oct; 19(1):233. PubMed ID: 31655540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling threshold phenomena, metabolic pathways switches and signals in chemostat-cultivated cells: the Crabtree effect in Saccharomyces cerevisiae.
    Thierie J
    J Theor Biol; 2004 Feb; 226(4):483-501. PubMed ID: 14759654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of in vivo fluxes through central metabolic pathways during the production of nystatin by Streptomyces noursei in batch culture.
    Jonsbu E; Christensen B; Nielsen J
    Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):93-100. PubMed ID: 11499953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using metabolic flux data to further constrain the metabolic solution space and predict internal flux patterns: the Escherichia coli spectrum.
    Wiback SJ; Mahadevan R; Palsson BØ
    Biotechnol Bioeng; 2004 May; 86(3):317-31. PubMed ID: 15083512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpretation of metabolic flux maps by limitation potentials and constrained limitation sensitivities.
    Wahl SA; Takors R; Wiechert W
    Biotechnol Bioeng; 2006 Jun; 94(2):263-72. PubMed ID: 16596665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CYP107Z13 in Streptomyces lividans TK54 catalyzes the oxidation of avermectin to 4″-oxo-avermectin.
    Jiang X; Liu W; Ji Y; Niu J; Li M
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1957-63. PubMed ID: 21842154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-scale metabolic model of Rhodococcus jostii RHA1 (iMT1174) to study the accumulation of storage compounds during nitrogen-limited condition.
    Tajparast M; Frigon D
    BMC Syst Biol; 2015 Aug; 9():43. PubMed ID: 26248853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic flux balancing elucidates NAD(P)H production as limiting response to furfural inhibition in Saccharomyces cerevisiae.
    Pornkamol U; Franzen CJ
    Biotechnol J; 2015 Aug; 10(8):1248-58. PubMed ID: 25880365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved oxytetracycline production in Streptomyces rimosus M4018 by metabolic engineering of the G6PDH gene in the pentose phosphate pathway.
    Tang Z; Xiao C; Zhuang Y; Chu J; Zhang S; Herron PR; Hunter IS; Guo M
    Enzyme Microb Technol; 2011 Jun; 49(1):17-24. PubMed ID: 22112266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating metabolic flux ratios into constraint-based flux analysis by using artificial metabolites and converging ratio determinants.
    Choi HS; Kim TY; Lee DY; Lee SY
    J Biotechnol; 2007 May; 129(4):696-705. PubMed ID: 17408794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased heterologous production of the antitumoral polyketide mithramycin A by engineered Streptomyces lividans TK24 strains.
    Novakova R; Núñez LE; Homerova D; Knirschova R; Feckova L; Rezuchova B; Sevcikova B; Menéndez N; Morís F; Cortés J; Kormanec J
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):857-869. PubMed ID: 29196786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses.
    Park JM; Kim TY; Lee SY
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14931-6. PubMed ID: 20679215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.